161 related articles for article (PubMed ID: 23992167)
1. Histological changes after treatment for localized fat deposits with phosphatidylcholine and sodium deoxycholate.
Park EJ; Kim HS; Kim M; Oh HJ
J Cosmet Dermatol; 2013 Sep; 12(3):240-3. PubMed ID: 23992167
[TBL] [Abstract][Full Text] [Related]
2. Histological changes associated with mesotherapy for fat dissolution.
Rose PT; Morgan M
J Cosmet Laser Ther; 2005 Mar; 7(1):17-9. PubMed ID: 16020211
[TBL] [Abstract][Full Text] [Related]
3. Tissue-toxic effects of phosphatidylcholine/deoxycholate after subcutaneous injection for fat dissolution in rats and a human volunteer.
Schuller-Petrovic S; Wölkart G; Höfler G; Neuhold N; Freisinger F; Brunner F
Dermatol Surg; 2008 Apr; 34(4):529-42; discussion 542-3. PubMed ID: 18370980
[TBL] [Abstract][Full Text] [Related]
4. Mixed cell granulomatous panniculitis on the cheek due to injection of a solution containing phosphatidylcholine and deoxycholate.
Kato M; Watanabe T; Yamada N; Yoshida Y; Yamamoto O
Dermatol Surg; 2010 Nov; 36(11):1779-81. PubMed ID: 20961354
[No Abstract] [Full Text] [Related]
5. Randomized double-blind clinical trial of subcutaneously injected deoxycholate versus a phosphatidylcholine-deoxycholate combination for the reduction of submental fat.
Rotunda AM; Weiss SR; Rivkin LS
Dermatol Surg; 2009 May; 35(5):792-803. PubMed ID: 19397673
[TBL] [Abstract][Full Text] [Related]
6. Submental fat reduction by mesotherapy using phosphatidylcholine alone vs. phosphatidylcholine and organic silicium: a pilot study.
Co AC; Abad-Casintahan MF; Espinoza-Thaebtharm A
J Cosmet Dermatol; 2007 Dec; 6(4):250-7. PubMed ID: 18047610
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and structural effects of phosphatidylcholine and deoxycholate injections on subcutaneous fat: a randomized, controlled trial.
Reeds DN; Mohammed BS; Klein S; Boswell CB; Young VL
Aesthet Surg J; 2013 Mar; 33(3):400-8. PubMed ID: 23439063
[TBL] [Abstract][Full Text] [Related]
8. Induction of fat cell necrosis in human fat tissue after treatment with phosphatidylcholine and deoxycholate.
Bechara FG; Mannherz HG; Jacob M; Mazur AJ; Sand M; Altmeyer P; Hoffmann K
J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):180-5. PubMed ID: 22280507
[TBL] [Abstract][Full Text] [Related]
9. Fat reduction using phosphatidylcholine/sodium deoxycholate injections: standard of practice.
Duncan DI; Palmer M
Aesthetic Plast Surg; 2008 Nov; 32(6):858-72. PubMed ID: 18612680
[TBL] [Abstract][Full Text] [Related]
10. Mixed-cell granulomatous panniculitis on the cheek due to injection of solution containing phosphatidylcholine and deoxycholate.
Rotunda AM
Dermatol Surg; 2010 Nov; 36(11):1782-5. PubMed ID: 20979342
[No Abstract] [Full Text] [Related]
11. Phosphatidylcholine in the treatment of localized fat.
Hexsel D; Serra M; Mazzuco R; Dal'Forno T; Zechmeister D
J Drugs Dermatol; 2003 Oct; 2(5):511-8. PubMed ID: 14558399
[TBL] [Abstract][Full Text] [Related]
12. Mesotherapy and phosphatidylcholine injections: historical clarification and review.
Rotunda AM; Kolodney MS
Dermatol Surg; 2006 Apr; 32(4):465-80. PubMed ID: 16681654
[TBL] [Abstract][Full Text] [Related]
13. A complication of mesotherapy: noninfectious granulomatous panniculitis.
Davis MD; Wright TI; Shehan JM
Arch Dermatol; 2008 Jun; 144(6):808-9. PubMed ID: 18559780
[No Abstract] [Full Text] [Related]
14. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution.
Rotunda AM; Suzuki H; Moy RL; Kolodney MS
Dermatol Surg; 2004 Jul; 30(7):1001-8. PubMed ID: 15209790
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylcholine and sodium deoxycholate in the treatment of localized fat: a double-blind, randomized study.
Salti G; Ghersetich I; Tantussi F; Bovani B; Lotti T
Dermatol Surg; 2008 Jan; 34(1):60-6; discussion 66. PubMed ID: 18053049
[TBL] [Abstract][Full Text] [Related]
16. Injection lipolysis for reduction of saddlebag trochanteric bulges--half-side controlled pilot study.
Kopera D; Horejsi R; Werner S; Moeller R
J Dtsch Dermatol Ges; 2008 Apr; 6(4):287-90. PubMed ID: 18081857
[TBL] [Abstract][Full Text] [Related]
17. Fat tissue after lipolysis of lipomas: a histopathological and immunohistochemical study.
Bechara FG; Sand M; Hoffmann K; Sand D; Altmeyer P; Stücker M
J Cutan Pathol; 2007 Jul; 34(7):552-7. PubMed ID: 17576334
[TBL] [Abstract][Full Text] [Related]
18. Histopathological and ultra-structural characterization of local neuromuscular damage induced by repeated phosphatidylcholine/deoxycholate injection.
El-Gowelli HM; El Sabaa B; Yosry E; El-Saghir H
Exp Toxicol Pathol; 2016 Jan; 68(1):39-46. PubMed ID: 26404917
[TBL] [Abstract][Full Text] [Related]
19. Cytokine mRNA levels in human fat tissue after injection lipolysis with phosphatidylcholine and deoxycholate.
Bechara FG; Skrygan M; Kreuter A; Altmeyer P; Gambichler T
Arch Dermatol Res; 2008 Sep; 300(8):455-9. PubMed ID: 18563422
[TBL] [Abstract][Full Text] [Related]
20. Recurrent growth of lipomas after previous treatment with phosphatidylcholine and deoxycholate.
Pindur L; Sand M; Altmeyer P; Bechara FG
J Cosmet Laser Ther; 2011 Apr; 13(2):95-6. PubMed ID: 21401383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
